Showing results (371-380 of 645) with videos related to

Sort By:
Pageof 65
Human Molecular Genetics|September 16, 1998
Characterization of a double homeodomain protein (DUX1) encoded by a cDNA homologous to 3.3 kb dispersed repeated elementsH Ding, M C Beckers, S Plaisance, et al.
Circulation|April 18, 2001
Deficiency of urokinase-type plasminogen activator-mediated plasmin generation impairs vascular remodeling during hypoxia-induced pulmonary hypertension in miceM Levi, L Moons, A Bouché, et al.
The Journal of Biological Chemistry|April 5, 1990
Biochemical and functional characterization of human tissue-type plasminogen activator variants obtained by deletion and/or duplication of structural/functional domainsH R Lijnen, L Nelles, B Van Hoef, et al.
Molecular Reproduction and Development|December 1, 1996
Pluripotential rabbit embryonic stem (ES) cells are capable of forming overt coat color chimeras following injection into blastocystsL Schoonjans, G M Albright, J L Li, et al.
Thrombosis and Haemostasis|August 6, 2000
Plasminogen binding properties of macrophage inflammatory protein (MIP)-2alphaB Arza, J Félez, P Fábregas, et al.
Thrombosis Research|March 1, 1984
Plasma levels of a specific inhibitor of tissue-type plasminogen activator (and urokinase) in normal and pathological conditionsI Juhan-Vague, B Moerman, F De Cock, et al.
Thrombosis and Haemostasis|January 1, 1994
Expression and characterization of clustered charge-to-alanine mutants of low M(r) single-chain urokinase-type plasminogen activatorS Ueshima, P Holvoet, H R Lijnen, et al.
Thrombosis and Haemostasis|August 20, 1986
Absence of synergism between tissue-type plasminogen activator (t-PA), single-chain urokinase-type plasminogen activator (scu-PA) and urokinase on clot lysis in a plasma milieu in vitroD Collen, F De Cock, E Demarsin, et al.
Circulation|September 1, 1991
Thrombolytic and pharmacokinetic properties of chimeric tissue-type and urokinase-type plasminogen activatorsD Collen, H R Lu, H R Lijnen, et al.
Thrombosis Research|October 15, 1985
Aspirin, indomethacin and dazoxiben do not affect the fibrinolytic activation induced by venous occlusionH Bounameaux, P Gresele, M Hanss, et al.
Pageof 65